Sunstar recalls gingivitis drug due to potential bacterial contamination

Sunstar said it is notifying its suppliers and customers by U.S. Postal Service priority mail and scheduling all impacted items to be returned. Patients, pharmacies and health care facilities need to stop using and dispensing the drug right away, the company stated..

More articles on pharmacy: FDA is letting COVID-19 vaccine makers avoid inspection before emergency situation authorizationVertex prompted to attend to fatal inequality in access to its cystic fibrosis drugCVS to include rapid COVID-19 screening at 1,000 drug stores.

Medical supply company Sunstar Americas is remembering its gingivitis oral rinse, proex chlorhexidine gluconate, after finding it may be contaminated with bacteria..

Maia Anderson –
Wednesday, October 28th, 2020
Print|Email.

The prescription oral rinse is designed to treat gingivitis and has been distributed nationwide to oral workplaces, oral distributors, pharmaceutical wholesalers, dental schools and drug stores..

Utilizing the remembered product might trigger systemic or oral infections needing antibacterial treatment, the business said. © Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material?

Check out the complete press release here.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

Using the remembered item might cause oral or systemic infections needing anti-bacterial treatment, the company stated. The drug might include Burkholderia lata, which in at-risk populations might cause life-threatening infections such as pneumonia and bacteremia. No negative events have been reported, Sunstar stated..